Table 1 Patient’s characteristic

Age (y)

75.9 (SD 5.7)

74.2 (SD 6.6)

74.1 (SD 6.6)

0.058

BSA (m²)

1.89 (SD 0.17)

1.93 (SD 0.13)

1.86 (SD 0.18)

0.11

Female gender; n (%)

24 (35.3)

8 (32.0)

16 (37.7)

>0.5

COPD; n (%)

7 (10.3)

2 (8)

5 (11.6)

>0.5

DM; n (%)

26 (38.2)

5 (20)

21 (48.8)

0.022

Creatinine (mg/dl)

1.10 (0.86–1.4)

1.01 (0.7–1.5)

1.20 (1.0–1.4)

0.31

CKD-EPI (ml/min/1,73 m²)

64.5 (SD 21.2)

69.8 (SD 27.0)

61.5 (SD 16.5)

0.18

Chronic AF; n (%)

15 (22.1)

7 (28)

8 (18.6)

0.38

PAVD; n (%)

9 (13.2)

3 (12)

6 (14)

>0.5

Stroke; n (%)

4(5.9)

2(8.0)

2(4.7)

>0.5

Art.hypertension; n(%)

63(94)

21(87.5)

42(97.7)

0.13

Pul. hypertension; n (%)

24(35.3)

7(28.0)

17(39.5)

0.43

NYHA class III -IV; n (%)

40 (58.8)

14 (56)

26 (60.5)

>0.5

LVEF (%)

54 (SD 12.8)

54.2 (SD 14.0)

53.9 (SD 12)

0.25

EuroSCORE II (%)

5.3 (3.7–8.9)

5.0 (3.1–9.1)

5.7 (3.9–9.0)

0.29

Preoperative EOA, cm²

0.78 (SD 0.22)

0.75 (SD 0.25)

0.79 (SD 0.19)

>0.5

Preoperative mean aortic valve gradient, mmHG

49.6 (SD 11.6)

48.8 (SD 12.7)

50.1 (SD 10.9)

>0.5